ইস্রায়েল - ইংরেজি - Ministry of Health

abic marketing ltd, israel - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemestane teva® is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane teva® is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies.exemestane teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy

ইস্রায়েল - ইংরেজি - Ministry of Health

abic marketing ltd, israel - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemestane teva® is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane teva® is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies.exemestane teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: stabilanol is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. stabilanol can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.consideration should be given to official guidance on the appropriate use of antifungals.

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: sta

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: sta

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: sta

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - naproxen sodium - tablets - naproxen sodium 275 mg - naproxen - naproxen - mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea).fever reduction.non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - naproxen sodium - tablets - naproxen sodium 275 mg - naproxen - naproxen - mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea).fever reduction.non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - lamotrigine - tablets - lamotrigine 25 mg - lamotrigine - lamotrigine - epilepsyadults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamogine is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox- gastaut syndrome.children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic- clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.bipolar disorderadults aged 18 years and above- prevention of depressive episodes in patients with bipolar i disorder who experience predominantly depressive episodes.lamogine is not indicated for the acute treatment of manic or depressive episodes.

ইস্রায়েল - ইংরেজি - Ministry of Health

trima israel pharmaceutical products maabarot ltd - lamotrigine - tablets - lamotrigine 50 mg - lamotrigine - lamotrigine - epilepsyadults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamogine is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox- gastaut syndrome.children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic- clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.bipolar disorderadults aged 18 years and above- prevention of depressive episodes in patients with bipolar i disorder who experience predominantly depressive episodes.lamogine is not indicated for the acute treatment of manic or depressive episodes.